Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy

NCT06790784 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT06790784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06790784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Recruiting
Start date
August 4, 2025
Completion date
August 31, 2031
Enrollment
426 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy (pdr)